BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 30334995)

  • 21. Pooled long-term outcomes from two randomized trials of axillary node sampling with axillary radiotherapy versus axillary node clearance in patients with operable node-positive breast cancer.
    Bing AU; Kerr GR; Jack W; Chetty U; Williams LJ; Rodger A; Dixon JM
    Br J Surg; 2016 Jan; 103(1):81-7. PubMed ID: 26768099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating cell-free DNA (cfDNA) levels in BRCA1 and BRCA2 mutation carriers: A preliminary study.
    Douvdevani A; Bernstein-Molho R; Asraf K; Doolman R; Laitman Y; Friedman E
    Cancer Biomark; 2020; 28(3):269-273. PubMed ID: 32280079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lobular invasive breast cancer prognostic factors: About 940 patients].
    Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
    Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Axillary and extra-axillary lymph node recurrences after a tumor-negative sentinel node biopsy for breast cancer using intralesional tracer administration.
    van der Ploeg IM; Kroon BB; Antonini N; Valdés Olmos RA; Rutgers EJ; Nieweg OE
    Ann Surg Oncol; 2008 Apr; 15(4):1025-31. PubMed ID: 18219534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-Free DNA Variables including Gene Mutations in CA15-3 Normal Breast Cancer Reflect Prognosis.
    Xu J; Chen W; Sun Z; Peng H; Zhou C; Pan S
    Dis Markers; 2022; 2022():5470166. PubMed ID: 35251373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discordance between number of scintigraphic and perioperatively identified sentinel lymph nodes and axillary tumour recurrence.
    Volders JH; van la Parra RF; Bavelaar-Croon CD; Barneveld PC; Ernst MF; Bosscha K; De Roos WK
    Breast; 2014 Apr; 23(2):159-64. PubMed ID: 24456968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?
    Rack B; Janni W; Gerber B; Strobl B; Schindlbeck C; Klanner E; Rammel G; Sommer H; Dimpfl T; Friese K
    Breast Cancer Res Treat; 2003 Nov; 82(2):83-92. PubMed ID: 14692652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of extranodal extension in axillary lymph node-positive breast cancer.
    Ma X; Yang X; Yang W; Shui R
    Sci Rep; 2021 May; 11(1):9534. PubMed ID: 33953240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymph node ratio is more predictive than traditional lymph node stratification in lymph node positive invasive breast cancer.
    Bai LS; Chen C; Gong YP; Wei W; Tu Y; Yao F; Li JJ; Wang LJ; Sun SR
    Asian Pac J Cancer Prev; 2013; 14(2):753-7. PubMed ID: 23621232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between FGFR1 copy numbers, MAP3K1 mutations, and survival in axillary node-positive, hormone receptor-positive, and HER2-negative early breast cancer in the PACS04 and METABRIC studies.
    Carene D; Tran-Dien A; Lemonnier J; Dalenc F; Levy C; Pierga JY; Jacot W; Canon JL; Richon C; Lacroix L; Caux C; André F; Michiels S
    Breast Cancer Res Treat; 2020 Jan; 179(2):387-401. PubMed ID: 31620934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histolopathologic approach to direct the management of the axilla in early breast cancer patients.
    Farid RM; Ahmed NS
    APMIS; 2014 Oct; 122(10):1032-41. PubMed ID: 24698490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recommendation for axillary lymph node dissection in women with early breast cancer and sentinel node metastasis: A systematic review and meta-analysis of randomized controlled trials using the GRADE system.
    Huang TW; Kuo KN; Chen KH; Chen C; Hou WH; Lee WH; Chao TY; Tsai JT; Su CM; Huang MT; Tam KW
    Int J Surg; 2016 Oct; 34():73-80. PubMed ID: 27562691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Axillary recurrences after sentinel lymph node biopsy: a multicentre analysis and follow-up of sentinel lymph node negative breast cancer patients".
    van Wely BJ; van den Wildenberg FJ; Gobardhan P; van Dalen T; Borel Rinkes IH; Theunissen EB; Wijsman JH; Ernst M; van der Pol CC; Madsen EV; Vles WJ; Wauters CA; de Wilt JH; Strobbe LJ
    Eur J Surg Oncol; 2012 Oct; 38(10):925-31. PubMed ID: 22633152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omission of axillary lymph node dissection for clinically node negative early-stage breast cancer patients.
    Kobayashi R; Shiraishi K; Iwase S; Ohtomo K; Nakagawa K
    Breast Cancer; 2015 Nov; 22(6):657-63. PubMed ID: 24756246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Axillary lymph node recurrence after sentinel lymph node biopsy for breast cancer].
    Mathelin C; Salvador S; Guyonnet JL
    J Gynecol Obstet Biol Reprod (Paris); 2007 May; 36(3):253-9. PubMed ID: 17317037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Spatiotemporal Evolution of Lymph Node Spread in Early Breast Cancer.
    Barry P; Vatsiou A; Spiteri I; Nichol D; Cresswell GD; Acar A; Trahearn N; Hrebien S; Garcia-Murillas I; Chkhaidze K; Ermini L; Huntingford IS; Cottom H; Zabaglo L; Koelble K; Khalique S; Rusby JE; Muscara F; Dowsett M; Maley CC; Natrajan R; Yuan Y; Schiavon G; Turner N; Sottoriva A
    Clin Cancer Res; 2018 Oct; 24(19):4763-4770. PubMed ID: 29891724
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-term breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes.
    Andersson Y; Bergkvist L; Frisell J; de Boniface J
    Breast Cancer Res Treat; 2018 Sep; 171(2):359-369. PubMed ID: 29846847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcome and axillary recurrence in elderly women (≥70 years) with breast cancer: 10-years follow-up from a matched cohort study.
    Corso G; Magnoni F; Montagna G; Maisonneuve P; Polizzi A; Massari G; Invento A; Girardi A; De Scalzi AM; Veronesi P
    Eur J Surg Oncol; 2021 Jul; 47(7):1593-1600. PubMed ID: 33685727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive value of circulating cell-free DNA in the survival of breast cancer patients: A systemic review and meta-analysis.
    Yang J; Cheng L; Zhang J; Chen L; Wang D; Guo X; Ma X
    Medicine (Baltimore); 2018 Jul; 97(28):e11417. PubMed ID: 29995790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. False-negative frozen section of sentinel nodes in early breast cancer (cT1-2N0) patients.
    Loh ZJ; Lee KT; Chen YP; Kuo YL; Chung WP; Hsu YT; Huang CC; Hsu HP
    World J Surg Oncol; 2021 Jun; 19(1):183. PubMed ID: 34158071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.